SOVREMENNAYA PEDIATRIYA.2014.2(58):70-75; doi 10.15574/SP.2014.58.70 
 

Endothelial function status in chldren with juvenil rheumatoid arthritis. 
 

Beregnoi V., Romankevych I.

P.L.Shupik National Medical Academy of Postgraduate Education, Kiev, Ukraine 

Cardio-vascular pathology is the main cause of death in patients with rheumatoid arthritis. Endothelial dysfunction is the first stage of vascular damage. The aim of our research was to complex study endothelial function and influence factors on endothelium. 
 

Materials and methods: 37 patients were examined during 2011–2013 years, 18 boys and 19 girls. The average age of the group was 11.87 ± 0.56 years. Mean disease duration was 3.45 ± 0.6 years. Flow-mediated dilatation (FMD) of the brachial artery, reactive hyperemia (RH), were used. 
 

Results: in children with JRA decries of FMD, RH, KV vs control group. In 10 (27%) children with JRA artery spasm was observed. The main factors which influence on endothelial function were disease activity and inflammatory markers, arterial blood pressure and it daily character and systemic glucocorticosteroid and folic acid used. 
 

Key words: juvenile rheumatoid arthritis, endothelial function. 
 

REFERENCES

1. Виноградов АА. 2006. Вазомоторная форма эндотелиальной дисфункции при системных васкулитах и системных заболеваниях соединительной ткани. Автореф дис канд мед наук.

2. Волосовець ОП, Кривопустов СП, Мороз ТС. 2007. Патогенетична роль оксиду азоту та ендотеліальної дисфункції в розвитку захворювань серцево-судинної системи у дітей. Здоровье ребёнка. 2(5): 33—38.

3. Головченко ЮИ, Трещинская МА. 2008. Обзор современных представлений об эндотелиальной дисфункции. CONSILIUM MEDICUM Ukraina. 11: 38—40.

4. Гончаренко Н И. 2010. Инструментальная диагностика ранних нарушений эндотелиальной функции у детей. Здоров’я України. 2(13): 50—51.

5. Клименко МО, Атаман ЮО. 2007. Атеросклероз як запалення. Експеримент та клін медицина. 4: 4—12.

6. Лупинская ЗА. 2003. Эндотелий сосудов — основной регулятор местного кровотока. Вестн Кыргызкого Российского славянского ун-та. 7: 14—18.

7. Bots ML, Westerink J, Rabelink TJ, de Koning EJP. 2005. Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response. European Heart Journal. 26(4): 363—368. http://dx.doi.org/10.1093/eurheartj/ehi017; PMid:15618057

8. Bacon Р. 2005. Atherosclerosis in Rheumatoid Arthritis. Rheumatologia. 21(3): 118—120.

9. Vlahos AP, Theocharis P, Bechlioulis A et al. 2011. Changes in Vascular Function and Structure in Juvenile Idiopathic Arthritis. Arthritis Care and Research. 63(12): 1736—1744. http://dx.doi.org/10.1002/acr.20613; PMid:21905249

10. Hafstrom I, Rohani M, Deneberg S et al. 2007. Effects of Low-dose Prednisolone on Endothelial Function, Atherosclerosis, and Traditional Risk Factors for Atherosclerosis in Patients with Rheumatoid Arthritis — A Randomized Study. The Journal of Rheumatology. 34: 1810—1816.

11. Kerekes G, Szekanecz Z, Der H et al. 2008. Endothelial Dysfunction and Atherosclerosis in Rheumatoid Arthritis: A Multiparametric Analysis Using Imaging Techniques and Laboratory Markers of Inflammation and Autoimmunit. The Journal of Rheumatology. 35: 398—406.

12. Peretz А, Leotta DF, Sullivan JH et al. 2007. Flow mediated dilation of the brachial artery: an investigation of methods requiring further standardization. BMC Cardiovascular Disorders. 7: 11.

13. Foster W, Carruthers D, Lip G, Blann A. 2010. Inflammation and Microvascular and Macrovascular Endothelial Dysfunction in Rheumatoid Arthritis: Effect of Treatment. The Journal of Rheumatology. 37;4: 711—716.

14. Kelm М. 2002. Flow-mediated dilatation in human circulation: diagnostic and therapeutic aspects. Am J of Physiology Heart. 282;1: 1—5.

15. Liang КР, Gabriel SE. 2007. Autoantibodies: Innocent Bystander or Key Player in Immunosenescence and Atherosclerosis? The Journal of Rheumatology. 34;6: 1203—1207.

16. Mehta D, Malik АВ. 2006. Signaling Mechanisms Regulating Endothelial Permeability. Physiol Rev. 86;1: 279—367.

17. Huemer M, Huemer C, Ulmer H, Crone J et al. 2005. No Evidence for Hyperhomocysteinemia or Increased Prevalence of Genetic Polymorphisms in the Homocysteine Pathway in Patients With Moderate Juvenile Idiopathic Arthritis. The Journal of Rheumatology. 32;1: 170—174.

18. Westerweel PE, Luyten R, Koomans HA et al. 2007. Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus. Arthritis and Rheum. 56;Issue 5: 1384—1396.

19. Bianchini E, Faita F, Gemignani V et al. 2006. The Assessment of Flow-Mediated Dilation(FMD) of the Brachial Artery. Computers in Cardiology. 33: 509—512.